References 1. Agency for Healthcare Research and Quality (AHRQ). Healthcare Cost and Utilization Project (HCUP); 2017. [cited 2017 04/19/ 2017]; Available from: https://www.ahrq.gov/research/data/hcup/ index.html. 2. Bachir BG, Kassouf W. Urinary… Click to show full abstract
References 1. Agency for Healthcare Research and Quality (AHRQ). Healthcare Cost and Utilization Project (HCUP); 2017. [cited 2017 04/19/ 2017]; Available from: https://www.ahrq.gov/research/data/hcup/ index.html. 2. Bachir BG, Kassouf W. Urinary diversions: advantages and disadvantages of the major types of diversions. Curr Opin Support Palliat Care. 2013;7:249–253. 3. Resnick MJ, Bassett JC, Clark PE. Management of superficial and muscle-invasive urothelial cancers of the bladder. Curr Opin Oncol. 2013;25:281–288. 4. Gore JL, Saigal CS, Hanley JM, Schonlau M, Litwin MS. P. Urologic Diseases in America. Variations in reconstruction after radical cystectomy. Cancer. 2006;107:729–737. 5. Evans B, Montie JE, Gilbert SM. Incontinent or continent urinary diversion: how to make the right choice. Curr Opin Urol. 2010;20:421–425. 6. Marko NF, Weil RJ. The role of observational investigations in comparative effectiveness research. Value Health. 2010;13:989– 997. 7. Curtis JP, Krumholz HM. The predicament of comparative effectiveness research using observational data. Ann Intern Med. 2015;163:799–800. 8. Goulart BH, Ramsey SD, Parvathaneni U. Observational study designs for comparative effectiveness research: an alternative approach to close evidence gaps in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2014;88:106–114. 9. Ross TR, Ng D, Brown JS, et al. The HMO research network virtual data warehouse: a public data model to support collaboration. EGEMS. 2014;2:1049. 10. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619. 11. Agresti A. Categorical Data Analysis. 3rd ed. Wiley; 2013:744. 12. Raudenbush SW, Bryk AS. Hierarchical Linear Models: Applications and Data Analysis Methods. SAGE Publications; 2002. 13. Skrondal A, Rabe-Hesketh S. Generalized Latent Variable Modeling: Multilevel, Longitudinal, and Structural Equation Models. CRC Press; 2004. 14. Hanley JA,McNeil BJ. Themeaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36. 15. Lemeshow S, Hosmer Jr. DW. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol. 1982;115:92–106. 16. Al-Radi OO, Harrell Jr. FE, Caldarone CA, et al. Case complexity scores in congenital heart surgery: a comparative study of the Aristotle Basic Complexity score and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) system. J Thorac Cardiovasc Surg. 2007;133:865–875. 17. Harrell Jr. FE. Regression Modeling Strategies. New York: Springer; 2001. 18. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 2013. 19. Hautmann RE. Which patients with transitional cell carcinoma of the bladder or prostatic urethra are candidates for an orthotopic neobladder? Curr Urol Rep. 2000;1:173–179. 20. Lee RK, Abol-Enein H, Artibani W, et al. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014;113:11–23. 21. Witjes JA, Comperat E, Cowan NC, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–792.
               
Click one of the above tabs to view related content.